TABLE 2.
Ophthalmology treatment details for the 29 Group C/D eyes in 22 eligible and evaluable patients
| Sub-Tenon’s Fascia
Carboplatin Administration |
Number of Local Therapies
Administered |
|||||
|---|---|---|---|---|---|---|
| ——— | ——— | |||||
| CEV* Course | Number Patients who Received | Minimum Dose | Maximum Dose | Laser of any kind only | Cryotherapy only | Laser and Cryotherapy |
| C Eyes (n= 4 total eyes) | ||||||
| 1 | 0 | N/A | N/A | 0 | 0 | 0 |
| 2 | 2 | 20 | 20 | 1 | 0 | 0 |
| 3 | 3 | 20 | 20 | 2 | 0 | 0 |
| 4 | 2 | 15 | 20 | 3 | 0 | 0 |
| 5 | 1 | 20 | 20 | 3 | 0 | 0 |
| 6 | 0 | N/A | N/A | 2 | 0 | 0 |
| D Eyes (n= 25 total eyes) | ||||||
| 1 | 9 | 20 | 20 | 4 | 0 | 0 |
| 2 | 23 | 15 | 20 | 6 | 1 | 0 |
| 3 | 20 | 10 | 20 | 7 | 0 | 0 |
| 4 | 16 | 10 | 20 | 7 | 2 | 1 |
| 5 | 2 | 20 | 20 | 7 | 3 | 2 |
| 6 | 0 | N/A | N/A | 7 | 1 | 1 |
*
CEV=Carboplatin, etoposide, vincristine